The breast imaging market is driven by a combination of factors, including the rising prevalence of breast cancer, increasing awareness about early detection, technological advancements in imaging modalities, and the growing demand for minimally invasive procedures. The market is also influenced by factors such as government initiatives to improve healthcare infrastructure, increasing investments in research and development, and the availability of reimbursement policies for breast imaging procedures. However, the market faces challenges such as high cost of equipment and procedures, and concerns regarding radiation exposure from certain imaging techniques. Additionally, the COVID-19 pandemic has impacted the breast imaging market, with delays in screening and diagnostic procedures due to social distancing protocols and reduced patient visits to healthcare facilities.
Global Breast Imaging Market is estimated to be valued at US$ 3,905.2 million in 2022 and is expected to exhibit a CAGR of 7.6% during the forecast period (2022-2030).
Major Players in the Breast Imaging Industry:
GE Healthcare
GE Healthcare was founded in 1892 and is headquartered in Chicago, Illinois. It operates in more than 160 countries and is a leading provider of medical imaging, monitoring, and diagnostics equipment, as well as healthcare IT solutions. In August, 2022 GE Healthcare, a leading global medical technology, diagnostics and digital solutions innovator, today announced its collaboration with Boston Scientific, a global medical device manufacturer, to provide end-to-end innovative interventional cardiac care solutions in India.
Siemens Healthcare GmbH
Siemens Healthcare GmbH, a subsidiary of Siemens AG, was founded in 1847 and is headquartered in Erlangen, Germany. It operates in over 70 countries and provides a range of medical imaging and laboratory diagnostics equipment, as well as healthcare IT solutions. In February, 2023 Siemens Healthineers, a leading medical technology company, and Unilabs, a leading diagnostic services provider, announced today a multi-year agreement valued at over €200 million. Unilabs has invested in Siemens Healthineers top-notch technology and will acquire more than 400 laboratory analyzers to further improve its laboratory infrastructure to offer an unparalleled service to its customers.
Seno Medical Instruments, Inc
Seno Medical Instruments, Inc. was founded in 2005 and is headquartered in San Antonio, Texas. It is a privately held company that develops and manufactures medical imaging devices for breast cancer diagnosis.
Koninklijke Philips N.V.,
Koninklijke Philips N.V., commonly known as Philips, was founded in 1891 and is headquartered in Amsterdam, Netherlands. It operates in more than 100 countries and provides a broad range of healthcare products and solutions, including medical imaging and diagnostic equipment, as well as healthcare IT solutions.
Fujifilm Holdings Corporation
Fujifilm Holdings Corporation was founded in 1934 and is headquartered in Tokyo, Japan. It operates in over 100 countries and provides a range of imaging and information solutions, including medical imaging equipment and diagnostic systems. In 2022, FUJIFILM Holdings Corporation announced the release of a new preclinical imaging system, called the In-Vivo Imaging System FX-PRO, which is capable of high-resolution imaging of small animals.
Hologic, Inc.
Hologic, Inc. was founded in 1985 and is headquartered in Marlborough, Massachusetts. It operates in over 50 countries and provides a range of diagnostic and medical imaging equipment, as well as surgical and medical products for women's health. In November, 2022 Hologic, Inc. announced that it has been awarded a $19 million contract from the Biomedical Advanced Research and Development Authority (BARDA) to support research and development efforts.